Your browser doesn't support javascript.
loading
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML.
Lambert, Juliette; Lambert, Jerome; Thomas, Xavier; Marceau-Renaut, Alice; Micol, Jean-Baptiste; Renneville, Aline; Clappier, Emmanuelle; Hayette, Sandrine; Récher, Christian; Raffoux, Emmanuel; Pigneux, Arnaud; Berthon, Celine; Terré, Christine; Celli-Lebras, Karine; Castaigne, Sylvie; Boissel, Nicolas; Rousselot, Philippe; Preudhomme, Claude; Dombret, Hervé; Duployez, Nicolas.
Affiliation
  • Lambert J; Department of Hematology-Oncology, Versailles Hospital, University Versailles-Saint-Quentin-en-Yvelines, Le Chesnay, France.
  • Lambert J; Department of Biostatistics, Saint-Louis University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Thomas X; Department of Hematology, Lyon-Sud University Hospital, Pierre Bénite, France.
  • Marceau-Renaut A; Laboratory of Hematology, Centre Hospitalier Universitaire (CHU) Lille, INSERM UMR-S 1277, Lille, France.
  • Micol JB; Department of Hematology, Gustave Roussy Institute, Villejuif, France.
  • Renneville A; Laboratory of Hematology, Centre Hospitalier Universitaire (CHU) Lille, INSERM UMR-S 1277, Lille, France.
  • Clappier E; Laboratory of Hematology, Saint-Louis University Hospital, AP-HP, Paris, France.
  • Hayette S; Department of Hematology, Lyon-Sud University Hospital, Pierre Bénite, France.
  • Récher C; Department of Hematology, Toulouse University Hospital, University Toulouse III, Toulouse, France.
  • Raffoux E; Department of Hematology, Saint-Louis University Hospital, AP-HP, Paris, France.
  • Pigneux A; Department of Hematology, Bordeaux University Hospital, INSERM 1035, Bordeaux, France.
  • Berthon C; Department of Hematology, CHU Lille, Lille, France.
  • Terré C; Laboratory of Cytogenetic, Versailles Hospital, Le Chesnay, France; and.
  • Celli-Lebras K; Coordination Office, Acute Leukemia French Association (ALFA), University Hematology Institute, Paris, France.
  • Castaigne S; Department of Hematology-Oncology, Versailles Hospital, University Versailles-Saint-Quentin-en-Yvelines, Le Chesnay, France.
  • Boissel N; Department of Hematology, Saint-Louis University Hospital, AP-HP, Paris, France.
  • Rousselot P; Department of Hematology-Oncology, Versailles Hospital, University Versailles-Saint-Quentin-en-Yvelines, Le Chesnay, France.
  • Preudhomme C; Laboratory of Hematology, Centre Hospitalier Universitaire (CHU) Lille, INSERM UMR-S 1277, Lille, France.
  • Dombret H; Department of Hematology, Saint-Louis University Hospital, AP-HP, Paris, France.
  • Duployez N; Laboratory of Hematology, Centre Hospitalier Universitaire (CHU) Lille, INSERM UMR-S 1277, Lille, France.
Blood Adv ; 5(23): 5258-5268, 2021 12 14.
Article in En | MEDLINE | ID: mdl-34625784
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspects: Patient_preference Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: Blood Adv Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspects: Patient_preference Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: Blood Adv Year: 2021 Document type: Article Affiliation country: Country of publication: